RBMXP3

Across TCGA pan-cancer cohorts, RBMXP3 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RBMXP3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RBMXP3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBMXP3 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

COAD, KICH, and THCA are the cancer types where RBMXP3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBMXP3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.110	<.001	6	view →
KICH	Female	II,III,IV	−0.061	.018	3	view →
THCA	All	III,IV	−0.040	.035	3	view →
CHOL	All	II,III,IV	+0.205	.021	2	view →
BRCA	All	All	+0.085	.037	2	view →
KIRC	Female	III,IV	+0.067	.022	2	view →
PRAD	All	All	+0.052	.002	2	view →
LIHC	Male	All	+0.072	.030	1	view →
LUSC	All	All	+0.051	.005	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RBMXP3–COAD

Open the COAD breakdown →